Logo image of ELN.MI

EL.EN. SPA (ELN.MI) Stock Fundamental Analysis

BIT:ELN - Euronext Milan - IT0005453250 - Common Stock - Currency: EUR

11.26  +0.03 (+0.27%)

Fundamental Rating

6

ELN gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 60 industry peers in the Health Care Equipment & Supplies industry. ELN gets an excellent profitability rating and is at the same time showing great financial health properties. ELN has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year ELN was profitable.
In the past year ELN had a positive cash flow from operations.
ELN had positive earnings in each of the past 5 years.
In the past 5 years ELN always reported a positive cash flow from operatings.
ELN.MI Yearly Net Income VS EBIT VS OCF VS FCFELN.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M

1.2 Ratios

ELN's Return On Assets of 6.67% is amongst the best of the industry. ELN outperforms 81.82% of its industry peers.
The Return On Equity of ELN (13.86%) is better than 83.64% of its industry peers.
ELN has a better Return On Invested Capital (11.35%) than 90.91% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ELN is significantly above the industry average of 7.96%.
Industry RankSector Rank
ROA 6.67%
ROE 13.86%
ROIC 11.35%
ROA(3y)7.06%
ROA(5y)6.32%
ROE(3y)16.14%
ROE(5y)13.82%
ROIC(3y)13.36%
ROIC(5y)11.54%
ELN.MI Yearly ROA, ROE, ROICELN.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15 20

1.3 Margins

ELN has a Profit Margin of 7.54%. This is in the better half of the industry: ELN outperforms 61.82% of its industry peers.
ELN's Profit Margin has improved in the last couple of years.
The Operating Margin of ELN (10.30%) is better than 63.64% of its industry peers.
ELN's Operating Margin has improved in the last couple of years.
ELN has a Gross Margin of 40.03%. This is in the lower half of the industry: ELN underperforms 70.91% of its industry peers.
ELN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 10.3%
PM (TTM) 7.54%
GM 40.03%
OM growth 3Y12.63%
OM growth 5Y4.08%
PM growth 3Y11.97%
PM growth 5Y7.5%
GM growth 3Y2.43%
GM growth 5Y-1.32%
ELN.MI Yearly Profit, Operating, Gross MarginsELN.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30 40

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ELN is still creating some value.
ELN has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for ELN has been increased compared to 5 years ago.
Compared to 1 year ago, ELN has an improved debt to assets ratio.
ELN.MI Yearly Shares OutstandingELN.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
ELN.MI Yearly Total Debt VS Total AssetsELN.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

ELN has an Altman-Z score of 3.62. This indicates that ELN is financially healthy and has little risk of bankruptcy at the moment.
ELN has a better Altman-Z score (3.62) than 74.55% of its industry peers.
ELN has a debt to FCF ratio of 1.42. This is a very positive value and a sign of high solvency as it would only need 1.42 years to pay back of all of its debts.
ELN's Debt to FCF ratio of 1.42 is amongst the best of the industry. ELN outperforms 94.55% of its industry peers.
ELN has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.07, ELN belongs to the best of the industry, outperforming 89.09% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 1.42
Altman-Z 3.62
ROIC/WACC1.45
WACC7.84%
ELN.MI Yearly LT Debt VS Equity VS FCFELN.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M

2.3 Liquidity

ELN has a Current Ratio of 1.90. This is a normal value and indicates that ELN is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.90, ELN is in line with its industry, outperforming 60.00% of the companies in the same industry.
A Quick Ratio of 1.19 indicates that ELN should not have too much problems paying its short term obligations.
ELN has a better Quick ratio (1.19) than 63.64% of its industry peers.
Industry RankSector Rank
Current Ratio 1.9
Quick Ratio 1.19
ELN.MI Yearly Current Assets VS Current LiabilitesELN.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

4

3. Growth

3.1 Past

ELN shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.31%.
The Earnings Per Share has been growing by 23.52% on average over the past years. This is a very strong growth
ELN shows a decrease in Revenue. In the last year, the revenue decreased by -4.71%.
ELN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.88% yearly.
EPS 1Y (TTM)-5.31%
EPS 3Y33.72%
EPS 5Y23.52%
EPS Q2Q%5.73%
Revenue 1Y (TTM)-4.71%
Revenue growth 3Y19.27%
Revenue growth 5Y14.88%
Sales Q2Q%-9.45%

3.2 Future

Based on estimates for the next years, ELN will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.77% on average per year.
Based on estimates for the next years, ELN will show a small growth in Revenue. The Revenue will grow by 4.00% on average per year.
EPS Next Y13.36%
EPS Next 2Y9.57%
EPS Next 3Y9.77%
EPS Next 5YN/A
Revenue Next Year-2.07%
Revenue Next 2Y2.52%
Revenue Next 3Y4%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ELN.MI Yearly Revenue VS EstimatesELN.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M
ELN.MI Yearly EPS VS EstimatesELN.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 18.16, which indicates a rather expensive current valuation of ELN.
Based on the Price/Earnings ratio, ELN is valued cheaper than 81.82% of the companies in the same industry.
ELN's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 29.35.
ELN is valuated correctly with a Price/Forward Earnings ratio of 15.31.
Based on the Price/Forward Earnings ratio, ELN is valued a bit cheaper than 78.18% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of ELN to the average of the S&P500 Index (22.10), we can say ELN is valued slightly cheaper.
Industry RankSector Rank
PE 18.16
Fwd PE 15.31
ELN.MI Price Earnings VS Forward Price EarningsELN.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

ELN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ELN is cheaper than 90.91% of the companies in the same industry.
96.36% of the companies in the same industry are more expensive than ELN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 14.62
EV/EBITDA 10.29
ELN.MI Per share dataELN.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

ELN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of ELN may justify a higher PE ratio.
PEG (NY)1.36
PEG (5Y)0.77
EPS Next 2Y9.57%
EPS Next 3Y9.77%

4

5. Dividend

5.1 Amount

ELN has a Yearly Dividend Yield of 1.78%. Purely for dividend investing, there may be better candidates out there.
ELN's Dividend Yield is a higher than the industry average which is at 2.26.
Compared to the average S&P500 Dividend Yield of 2.33, ELN is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.78%

5.2 History

The dividend of ELN is nicely growing with an annual growth rate of 16.70%!
Dividend Growth(5Y)16.7%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

ELN pays out 34.24% of its income as dividend. This is a sustainable payout ratio.
The dividend of ELN is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP34.24%
EPS Next 2Y9.57%
EPS Next 3Y9.77%
ELN.MI Yearly Income VS Free CF VS DividendELN.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M
ELN.MI Dividend Payout.ELN.MI Dividend Payout, showing the Payout Ratio.ELN.MI Dividend Payout.PayoutRetained Earnings

EL.EN. SPA

BIT:ELN (3/7/2025, 7:00:00 PM)

11.26

+0.03 (+0.27%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-14 2024-11-14
Earnings (Next)03-13 2025-03-13/amc
Inst Owners28.7%
Inst Owner ChangeN/A
Ins Owners35.63%
Ins Owner ChangeN/A
Market Cap902.15M
Analysts82.86
Price Target13.87 (23.18%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.78%
Yearly Dividend0.24
Dividend Growth(5Y)16.7%
DP34.24%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)5.58%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.03%
Valuation
Industry RankSector Rank
PE 18.16
Fwd PE 15.31
P/S 1.37
P/FCF 14.62
P/OCF 12.48
P/B 2.51
P/tB 2.61
EV/EBITDA 10.29
EPS(TTM)0.62
EY5.51%
EPS(NY)0.74
Fwd EY6.53%
FCF(TTM)0.77
FCFY6.84%
OCF(TTM)0.9
OCFY8.01%
SpS8.23
BVpS4.48
TBVpS4.32
PEG (NY)1.36
PEG (5Y)0.77
Profitability
Industry RankSector Rank
ROA 6.67%
ROE 13.86%
ROCE 15.64%
ROIC 11.35%
ROICexc 17.83%
ROICexgc 18.69%
OM 10.3%
PM (TTM) 7.54%
GM 40.03%
FCFM 9.35%
ROA(3y)7.06%
ROA(5y)6.32%
ROE(3y)16.14%
ROE(5y)13.82%
ROIC(3y)13.36%
ROIC(5y)11.54%
ROICexc(3y)23.42%
ROICexc(5y)19.85%
ROICexgc(3y)24.46%
ROICexgc(5y)20.64%
ROCE(3y)18.42%
ROCE(5y)15.91%
ROICexcg growth 3Y11.02%
ROICexcg growth 5Y6.62%
ROICexc growth 3Y10.44%
ROICexc growth 5Y6.28%
OM growth 3Y12.63%
OM growth 5Y4.08%
PM growth 3Y11.97%
PM growth 5Y7.5%
GM growth 3Y2.43%
GM growth 5Y-1.32%
F-Score6
Asset Turnover0.88
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 1.42
Debt/EBITDA 0.32
Cap/Depr 88.28%
Cap/Sales 1.6%
Interest Coverage 22.58
Cash Conversion 90.43%
Profit Quality 123.98%
Current Ratio 1.9
Quick Ratio 1.19
Altman-Z 3.62
F-Score6
WACC7.84%
ROIC/WACC1.45
Cap/Depr(3y)149.47%
Cap/Depr(5y)177.42%
Cap/Sales(3y)2.33%
Cap/Sales(5y)2.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.31%
EPS 3Y33.72%
EPS 5Y23.52%
EPS Q2Q%5.73%
EPS Next Y13.36%
EPS Next 2Y9.57%
EPS Next 3Y9.77%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.71%
Revenue growth 3Y19.27%
Revenue growth 5Y14.88%
Sales Q2Q%-9.45%
Revenue Next Year-2.07%
Revenue Next 2Y2.52%
Revenue Next 3Y4%
Revenue Next 5YN/A
EBIT growth 1Y-13.49%
EBIT growth 3Y34.32%
EBIT growth 5Y19.56%
EBIT Next Year26.21%
EBIT Next 3Y14.26%
EBIT Next 5YN/A
FCF growth 1Y678.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1095.57%
OCF growth 3Y-32.33%
OCF growth 5Y0.48%